1. 1) Pawankar R, Canonica GW, Holgate ST, Lockey RF, Blaiss M. “The WAO White Book on Allergy (update 2013).” World Allergy Organization; 2013.: ‹www.worldallergy.org› accessed December 3, 2015.
2. 2) Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines–2016 revision. J. Allergy Clin. Immunol., 140, 950–958 (2017).
3. 3) Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J., 7, 6 (2014).
4. 4) GINA 2018: Global Initiative for Asthma. “Global Strategy for Asthma Management and Prevention, 2018.”: ‹www.ginasthma.org›.
5. 5) Green W, Kleine-Tebbe J, Klimek L, Hahn-Pedersen J, Norgaard Andreasen J, Taylor M. Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany. Clinicoecon. Outcomes Res., 9, 77–84 (2017).